🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Poland / NCT07659860
Recruiting Observational

Remodelling of the Lower Airways in Chronic Cough

NCT07659860 · tracked via the Priya Life Science Poland tracker
Phase
Observational
Started
2022-10-01
Last updated
2026-06-22

Condition(s) studied

Chronic Cough

Investigational drug(s) / intervention(s)

chest computed tomography and bronchoscopy

chest computed tomography and bronchoscopy: Assessment of airway remodeling features on chest CT in patients with chronic cough. Evaluation of airway injury and remodeling based on biological specimens obtained from the lower airways during bronchoscopy.Bronchoscopy is performed if clinically indicated.

Study summary

The aim of the study is to assess if chronic cough leads to injury and remodelling of the airways. We plan to analyse bronchial injury and remodelling in patients with refractory chronic cough lasting longer than 12 month . Assessment of injury mediators will be performed in blood and bronchoalveolar lavage fluid. Remodelling features will be analysed based on chest CT scan and pathologic specimens. Injury of epithelium will be assessed in bronchial biopsy specimens. The relationship between the duration, severity of chronic cough, and bronchial inflammation, damage, remodelling will be analysed.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion criteria for the study group: 1. age between 18 and 75 years, 2. chronic cough of at least one year duration, with no previous treatment (at least 2 previous unsuccessful attempts at pharmacological treatment of cough) 3. negative history of smoking (at least 6 months of abstinence), 4. negative history of treatment with angiotensin-converting enzyme inhibitors (ACEI), 5. normal chest radiograph or with changes not relevant to cough formation, 6. no respiratory tract infections in the past 6 weeks, 7. written consent from the patient to participate in the study. Exclusion Criteria: 1. patients less than 18 and more than 75 years of age, 2. cough lasting less than 12 months, 3. active smoking or abstinence period of less than 6 months, 4. respiratory tract infection 6 weeks prior to inclusion or at the time of study conduct - retry inclusion after 6 weeks, 5. cancer or interstitial lung disease, 6. contraindications to functional testing, sputum induction or bronchoscopy

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw Warsaw Masovian Voivodeship Recruiting
Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw Warsaw Warsaw Recruiting
Medical University of Warsaw Warsaw Poland Recruiting
Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw Warsaw Poland Recruiting

More Medical University of Warsaw trials in Poland

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07659860 on ClinicalTrials.gov ↗ ← All trials in Poland